Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biogen Idec (NQ: BIIB ) 190.80 -3.04 (-1.57%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biogen Idec < Previous 1 2 3 4 5 6 7 8 9 ... 47 48 Next > BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm May 28, 2024 From Bragar Eagel & Squire Via GlobeNewswire Biogen Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against BIIB May 28, 2024 From Robbins LLP Via Business Wire BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline May 28, 2024 From Bernstein Liebhard LLP Via GlobeNewswire Deep Dive Into Biogen Stock: Analyst Perspectives (17 Ratings) May 22, 2024 Via Benzinga How Is The Market Feeling About Biogen? May 20, 2024 Via Benzinga BIOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm May 24, 2024 From Bragar Eagel & Squire Via GlobeNewswire Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB) May 24, 2024 From Robbins LLP Via GlobeNewswire BIOGEN INC. (NASDAQ: BIIB) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Biogen Inc. May 24, 2024 From Bernstein Liebhard LLP Via GlobeNewswire The Analyst Landscape: 27 Takes On Biogen April 29, 2024 Via Benzinga Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week April 29, 2024 With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. Via Benzinga Topics Stocks Exposures US Equities Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors May 23, 2024 From Kirby McInerney LLP Via Business Wire BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! May 23, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Biogen Inc. with Losses to Contact the Firm May 23, 2024 From Schall Law Via GlobeNewswire These Analysts Revise Their Forecasts On Biogen After Q1 Results April 25, 2024 Via Benzinga BIIB INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Biogen Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit May 23, 2024 From Robbins Geller Rudman & Dowd LLP Via Business Wire Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences May 22, 2024 From Biogen Inc. Via GlobeNewswire Larimar Therapeutics' Friedreich's Ataxia Investigational Drug Differentiated From Biogen's Marketed Drug May 21, 2024 Larimar Therapeutics announces FDA lift of partial clinical hold on nomlabofusp (CTI-1601) for Friedreich's Ataxia. Data from Phase 2 study shows well-tolerated treatment with significant frataxin... Via Benzinga Exposures Product Safety Large Cap Biopharmaceuticals Performance May 20, 2024 The biotech sector remains a laggard YTD as can be seen by the IBB. Via Talk Markets Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 May 17, 2024 With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. Via InvestorPlace Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another May 16, 2024 Ionis Pharmaceuticals and Biogen have halted development of BIIB105 for ALS after Phase 1/2 study results showed no impact on key clinical outcomes. Via Benzinga Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis May 16, 2024 From Biogen Inc. Via GlobeNewswire Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment May 15, 2024 The company is hoping to launch an under-the-skin version of its infusion, Leqembi. Via Investor's Business Daily Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status May 14, 2024 From Biogen Inc. Via GlobeNewswire Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank May 13, 2024 Jim Cramer recommends buying Micron, adding that he likes the company's CEO Sanjay Mehrotra. As for Fidelis? "Not a favorite." Via Benzinga 3 S&P 500 Stocks to Rival Nvidia’s 2023 Performance in the Second Half of 2024 May 11, 2024 Let’s explore three stocks that are well-positioned to rival Nvidia’s growth rates in the second half of 2024. Via InvestorPlace Topics Stocks Exposures US Equities The 3 Most Undervalued Pharma Stocks to Buy in May 2024 May 09, 2024 Investors looking for good deals in the pharmaceutical industry should watch out for these three undervalued pharma stocks. Via InvestorPlace Why Is Nuvo Group (NUVO) Stock Up 200% Today? May 06, 2024 Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. Via InvestorPlace Biogen Reports Progress on Corporate Responsibility Priorities May 02, 2024 From Biogen Inc. Via GlobeNewswire 7 Retirement Stocks to Buy at a 52-Week Low in April April 29, 2024 One of the best ways to keep your portfolio safe while generating income is with dividend-paying retirement stocks at 52-week lows. Via InvestorPlace Topics Retirement Exposures Pension Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review April 26, 2024 Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. Via Investor's Business Daily < Previous 1 2 3 4 5 6 7 8 9 ... 47 48 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.